CN106366081A - Green synthesis method for bicyclic pyridone compound - Google Patents
Green synthesis method for bicyclic pyridone compound Download PDFInfo
- Publication number
- CN106366081A CN106366081A CN201610734413.1A CN201610734413A CN106366081A CN 106366081 A CN106366081 A CN 106366081A CN 201610734413 A CN201610734413 A CN 201610734413A CN 106366081 A CN106366081 A CN 106366081A
- Authority
- CN
- China
- Prior art keywords
- reaction
- compound
- synthesis method
- bicyclic
- green synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
本发明公开了一种双环吡啶酮化合物的绿色合成方法。本发明的技术方案要点为:一种双环吡啶酮化合物的绿色合成,是以杂环烯酮缩胺及其衍生物与乙氧基甲叉丙二酸二乙酯为原料,在无溶剂、无催化剂超声促进或微波促进条件下通过一锅法串联反应一步成环而制得,公布了具体的合成步骤及制备过程中的主要反应方程式。本发明具有制备简单高效、安全环保、反应条件温和等优点,符合现代绿色化学特点,具工业化应用前景。The invention discloses a green synthesis method of a bicyclic pyridone compound. The key points of the technical scheme of the present invention are: a kind of green synthesis of bicyclic pyridone compound is to use heterocyclic ketene ketamine and its derivatives and diethyl ethoxymethylene malonate as raw materials in a solvent-free, The catalyst is prepared by one-pot cascading reaction and one-step ring formation under the condition of ultrasonic promotion or microwave promotion, and the specific synthesis steps and the main reaction equation in the preparation process are announced. The invention has the advantages of simple and efficient preparation, safety and environmental protection, mild reaction conditions, etc., conforms to the characteristics of modern green chemistry, and has industrial application prospects.
Description
技术领域technical field
本发明涉及有机合成化学领域,具体说是一种双环吡啶酮化合物的绿色合成方法。The invention relates to the field of organic synthesis chemistry, in particular to a green synthesis method of bicyclic pyridone compounds.
背景技术Background technique
双环吡啶酮化合物是药物和染料常见的结构单元,是许多天然的生物碱、嘌呤碱和许多有重要活性的天然产物以及有机合成中间体的基本骨架。广泛分布于动植物中,也可以在农药中做除草剂。双环吡啶酮类杂环化合物因其突出的生物活性而在制药工业领域扮演着重要角色,不仅具抗疟疾、抗糖尿病、抗肿瘤、抗炎、抗病毒、抗真菌等良好的生理活性,而且可作为人体鼻病毒3C-蛋白酶抑制剂、ACE抑制剂、周期素激酶抑制剂、钙通道阻滞剂等而发挥药理作用(Gudmundsson, s.; J. Med. Chem.2003, 46, 1449; Rival, Y.;Omni. Pharm. Bull.1992, 40, 1170;Hranjec, M.; J. Med. Chem.2007, 50, 5659;Trapani, G.; J. Med. Chem. 1999,42,3934; Byth, F.; Bioorg. Med. Chem. Lett.2004, 14, 2245)。而双环吡啶酮类化合物的合成却具有一定的局限性,以反应需加热回流或使用催化剂、特定溶剂等,反应条件相对苛刻或者反应时间较长,不符合环境友好、绿色化学的要求。对于反应体系与条件的优化将为更好的发挥其实用价值奠定良好的基础。Bicyclic pyridone compounds are common structural units of drugs and dyes, and are the basic skeletons of many natural alkaloids, purine bases, many natural products with important activities, and intermediates in organic synthesis. Widely distributed in animals and plants, it can also be used as herbicide in pesticides. Bicyclic pyridone heterocyclic compounds play an important role in the field of pharmaceutical industry because of their outstanding biological activities. As a human rhinovirus 3C-protease inhibitor, ACE inhibitor, cyclin kinase inhibitor, calcium channel blocker, etc., it exerts pharmacological effects (Gudmundsson, s.; J. Med. Chem. 2003, 46, 1449 ; Rival, Y.; Omni. Pharm. Bull. 1992, 40, 1170 ; Hranjec , M.; J. Med. Chem. 2007 , 50, 5659 ; Trapani, G.; , F.; Bioorg. Med. Chem. Lett. 2004, 14, 2245 ). However, the synthesis of bicyclic pyridone compounds has certain limitations. The reaction requires heating to reflux or the use of catalysts, specific solvents, etc. The reaction conditions are relatively harsh or the reaction time is long, which does not meet the requirements of environmental friendliness and green chemistry. The optimization of the reaction system and conditions will lay a good foundation for better exerting its practical value.
发明内容Contents of the invention
本发明为了克服上述双环吡啶酮类化合物合成反应条件苛刻,反应时间长等缺点,公布了一种原料廉价易得、操作简单的双环吡啶酮类化合物的绿色高效合成方法。In order to overcome the disadvantages of harsh synthesis reaction conditions and long reaction time of the above-mentioned bicyclic pyridone compounds, the present invention discloses a green and efficient synthesis method of bicyclic pyridone compounds with cheap and easy-to-obtain raw materials and simple operation.
本发明的具体实施路线为:取杂环烯酮缩胺及其衍生物于反应器中,并称取一定量乙氧基甲叉丙二酸二乙酯滴入反应器,在无溶剂、无催化剂超声促进或微波促进条件下通过一锅法串联反应一步成环分别得对应的双环吡啶酮类产物,经过硅胶柱层析,减压蒸馏,重结晶得目标产物纯品。The specific implementation route of the present invention is: take heterocyclic ketene ketamine and its derivatives in the reactor, and take a certain amount of diethyl ethoxymethylene malonate dropwise into the reactor. Under the condition of ultrasonic promotion or microwave promotion of the catalyst, the corresponding bicyclic pyridone products are respectively obtained through one-pot series reaction one-step ring formation, and the pure product of the target product is obtained through silica gel column chromatography, vacuum distillation and recrystallization.
其中反应式如下:Wherein the reaction formula is as follows:
其中,R可为H、烷基或芳香基;Wherein, R can be H, alkyl or aryl;
R1为吸电子基,如硝基、氰基、酯基、卤原子或芳香酮基等;R1 is an electron-withdrawing group, such as a nitro group, a cyano group, an ester group, a halogen atom or an aromatic ketone group, etc.;
上述反应无论是室温搅拌、超声促进还是微波促进条件下均可发生。The above reaction can take place no matter it is stirred at room temperature, accelerated by ultrasound or accelerated by microwave.
上述反应无论是室温搅拌、超声促进还是微波促进条件,均可在有溶剂如:二氯甲烷、乙腈、1,4-二氧六环、丙酮、三乙胺、乙酸、二苯醚等和无溶剂时,一定程度得到对应的双环吡啶酮类产物,但无溶剂条件下反应产率更高。Whether the above reaction is stirred at room temperature, ultrasonically promoted or microwave-promoted, it can be carried out in solvents such as dichloromethane, acetonitrile, 1,4-dioxane, acetone, triethylamine, acetic acid, diphenyl ether, etc. and without When the solvent is used, the corresponding bicyclic pyridone products are obtained to a certain extent, but the reaction yield is higher under solvent-free conditions.
上述反应在有催化剂NaH、BuOK、三乙胺、乙酸等的存在下也可少量得到对应产物,但无催化剂时,反应产率更高。The above reaction can also obtain a small amount of corresponding products in the presence of catalysts NaH, BuOK, triethylamine, acetic acid, etc., but when there is no catalyst, the reaction yield is higher.
上述反应高温反应也可一定程度得到预期产物,但反应体系较为复杂,对分离纯化技术要求较高。The above-mentioned high-temperature reaction can also obtain the expected product to a certain extent, but the reaction system is relatively complicated, and the requirements for separation and purification technology are relatively high.
其中,所有反应由TLC点板监控。Among them, all reactions were monitored by TLC spots.
其中,所有反应通过硅胶柱层析分离纯化,并重结晶得纯净的双环吡啶酮类产物,核磁共振谱、高分辨质谱等表征手段对产物结构进行鉴定。Among them, all the reactions were separated and purified by silica gel column chromatography, and recrystallized to obtain pure bicyclic pyridone products, and the structure of the products was identified by NMR, high-resolution mass spectrometry and other characterization means.
上述反应均在无溶剂无催化剂参与条件下反应产率更高,且选用超声促进或微波促进缩短了反应时间,一步串联成环无需中间处理,具有原料廉价易得、操作简便、反应条件温和、环境友好、绿色高效等诸多优点。The above reactions all have higher reaction yields under the conditions of solvent-free and catalyst-free conditions, and the use of ultrasonic promotion or microwave promotion shortens the reaction time, and one-step series ring formation does not require intermediate treatment. The raw materials are cheap and easy to obtain, easy to operate, and the reaction conditions are mild. Environmentally friendly, green and efficient, and many other advantages.
上述所有反应的核磁共振数据由Bruker Ultrashield™ 400 PLUS/BrukerAVANCE III 400M型核磁谱仪测定,TMS为内标,瑞士Bruker公司。The nuclear magnetic resonance data of all above-mentioned reactions were measured by Bruker Ultrashield™ 400 PLUS/BrukerAVANCE III 400M nuclear magnetic spectrometer, TMS was the internal standard, Swiss Bruker company.
上述所有反应的高分辨质谱由 LTQ Orbitrap XL高分辨液相色谱质联用仪测定,美国Thermo Fisher Scientific公司。The high-resolution mass spectra of all the above reactions were determined by LTQ Orbitrap XL high-resolution liquid chromatography-mass spectrometry, Thermo Fisher Scientific, USA.
具体实施方式detailed description
实施例1 称取化合物2-(苯甲酰基亚甲基)咪唑啉啶(1mmol,188.2mg)于反应试管中,再缓慢向反应试管中滴入乙氧基甲叉丙二酸二乙酯(5mmol,1081.1mg),在超声促进下25-30℃反应5小时,TLC点板监控反应,待反应充分后,反应混合物经过硅胶柱层析,减压旋蒸得白色固体,重结晶得纯净的白色针状晶体产物双环吡啶酮化合物1。化合物数据为:Example 1 Weigh the compound 2-(benzoylmethylene)imidazolidinidine (1mmol, 188.2mg) in a reaction test tube, and slowly drop into the reaction test tube diethyl ethoxymethylene malonate ( 5mmol, 1081.1mg), reacted at 25-30°C for 5 hours under the promotion of ultrasound, and monitored the reaction by TLC spot plate. After the reaction was complete, the reaction mixture was subjected to silica gel column chromatography and rotary evaporation under reduced pressure to obtain a white solid. Bicyclopyridone compound 1 is the product of white needle crystals. The compound data is:
1 1
yield 69.8%; White needle-like crystals;1H NMR (400 MHz, CDCl3): δ= 1.32(t, J= 7.04, 3H,CH3), 4.06(t, J= 9.64, 2H, NCH2), 4.26-4.33(m, 4H, CONCH2 andCOOCH2), 7.49-7.58(m, 5H, ArH), 8.51 (s, 1H, CH), 8.75 (br, 1H, NH); HRMS(ESI-TOF+): m/z Calcd for C17H16O4N2Na[(M+Na)+] 335.1002; found, 335.0995.yield 69.8%; White needle-like crystals; 1 H NMR (400 MHz, CDCl 3 ): δ = 1.32(t, J = 7.04 , 3H,CH 3 ), 4.06(t, J = 9.64 , 2H, NCH 2 ) , 4.26-4.33(m, 4H, CONCH 2 andCOOCH 2 ), 7.49-7.58(m, 5H, ArH), 8.51 (s, 1H, CH), 8.75 (br, 1H, NH); HRMS(ESI-TOF + ): m/z Calcd for C 17 H 16 O 4 N 2 Na[(M+Na) + ] 335.1002; found, 335.0995.
实施例2 称取2-(对甲基苯甲酰基亚甲基)咪唑啉啶(1mmol,202.3mg)于反应试管中,再缓慢向反应试管中滴入乙氧基甲叉丙二酸二乙酯(5mmol,1081.1mg),在超声促进下25-30℃反应5小时,TLC点板监控反应,待反应充分后,反应混合物经过硅胶柱层析,减压旋蒸得白色固体,重结晶得纯净的白色针状晶体产物双环吡啶酮化合物2。化合物数据为:Example 2 Weigh 2-(p-methylbenzoylmethylene)imidazolidinidine (1mmol, 202.3mg) into a reaction test tube, and then slowly drop into the reaction test tube diethyl ethoxymethylenemalonate Ester (5mmol, 1081.1mg), reacted at 25-30°C for 5 hours under the promotion of ultrasound, and monitored the reaction by TLC spot plate. After the reaction was complete, the reaction mixture was subjected to silica gel column chromatography, and the white solid was obtained by rotary evaporation under reduced pressure, which was recrystallized to obtain The pure white needle crystal product bicyclopyridone compound 2. The compound data is:
2 2
yield 71.1%; White needle-like crystals; 1H NMR (400 MHz, CDCl3): δ= 1.33(t, J= 7.08, 3H,CH3), 2.42(s, 3H,ArCH3), 4.04(t, J= 9.76, 2H, NCH2), 4.26-4.32(m, 4H, CONCH2 and COOCH2), 7.28(d, J= 7.84, 2H, ArH), 7.47(d, J= 7.84, 2H,ArH), 8.53 (s, 1H, CH), 8.74 (br, 1H, NH); HRMS (ESI-TOF+): m/z Calcd forC18H18O4N2Na[(M+Na)+] 349.1159; found, 349.1156.yield 71.1%; White needle-like crystals; 1 H NMR (400 MHz, CDCl 3 ): δ = 1.33(t, J = 7.08 , 3H,CH 3 ), 2.42(s, 3H,ArCH 3 ), 4.04(t , J = 9.76 , 2H, NCH 2 ), 4.26-4.32(m, 4H, CONCH 2 and COOCH 2 ), 7.28(d, J = 7.84, 2H, ArH), 7.47(d, J = 7.84, 2H,ArH ), 8.53 (s, 1H, CH), 8.74 (br, 1H, NH); HRMS (ESI-TOF + ): m/z Calcd for C 18 H 18 O 4 N 2 Na[(M+Na) + ] 349.1159 ; found, 349.1156.
实施例3 称取2-(对甲氧基苯甲酰基亚甲基)咪唑啉啶(1mmol,218.2mg)于反应试管中,再缓慢向反应试管中滴入乙氧基甲叉丙二酸二乙酯(5mmol,1081.1mg),在超声促进下25-30℃反应5小时,TLC点板监控反应,待反应充分后,反应混合物经过硅胶柱层析,减压旋蒸得白色固体,重结晶得纯净的白色针状晶体双环吡啶酮化合物3。化合物数据为:Example 3 Weigh 2-(p-methoxybenzoylmethylene)imidazolinidine (1mmol, 218.2mg) into a reaction test tube, and then slowly drop ethoxymethylenemalonate di Ethyl ester (5mmol, 1081.1mg) was reacted at 25-30°C for 5 hours under the promotion of ultrasound, and the reaction was monitored by TLC spot plate. After the reaction was complete, the reaction mixture was subjected to silica gel column chromatography and rotary evaporation under reduced pressure to obtain a white solid, which was recrystallized The pure white needle-like bicyclopyridone compound 3 was obtained. The compound data is:
3 3
yield 75.4%; White needle-like crystals; 1H NMR (400 MHz, CDCl3): δ= 1.33(t, J= 7.08, 3H,CH3), 3.87(s, 3H, OCH3), 4.03(t, J= 9.56, 2H, NCH2), 4.27-4.32(m, 4H, CONCH2 and COOCH2), 6.98(d, J= 8.40, 2H, ArH), 7.58(d, J= 8.40, 2H,ArH), 8.56 (s, 1H, CH), 8.70 (br, 1H, NH); HRMS (ESI-TOF+): m/z Calcd forC18H18O5N2Na[(M+Na)+] 365.1108; found, 365.1107.yield 75.4%; White needle-like crystals; 1 H NMR (400 MHz, CDCl 3 ): δ = 1.33(t, J = 7.08 , 3H,CH 3 ), 3.87(s, 3H, OCH 3 ), 4.03(t , J = 9.56 , 2H, NCH 2 ), 4.27-4.32(m, 4H, CONCH 2 and COOCH 2 ), 6.98(d, J = 8.40, 2H, ArH), 7.58(d, J = 8.40, 2H,ArH ), 8.56 (s, 1H, CH), 8.70 (br, 1H, NH); HRMS (ESI-TOF + ): m/z Calcd for C 18 H 18 O 5 N 2 Na[(M+Na) + ] 365.1108 ; found, 365.1107.
实施例4 称取化合物2-(对氯苯甲酰基亚甲基)咪唑啉啶(1mmol,222.7mg)于反应试管中,再缓慢向反应试管中滴入化合物1(5mmol,1081.1mg),在超声促进下25-30℃反应5小时,TLC点板监控反应,待反应充分后,反应混合物经过硅胶柱层析,减压旋蒸得白色固体,重结晶得纯净的白色针状晶体双环吡啶酮化合物4。化合物数据为:Example 4 Weigh compound 2-(p-chlorobenzoylmethylene)imidazolidinium (1mmol, 222.7mg) in a reaction test tube, and then slowly drop compound 1 (5mmol, 1081.1mg) into the reaction test tube. Under the promotion of ultrasound, react at 25-30°C for 5 hours, and monitor the reaction by spotting TLC plate. After the reaction is complete, the reaction mixture is subjected to silica gel column chromatography and rotary evaporation under reduced pressure to obtain a white solid, which is recrystallized to obtain pure white needle-shaped bicyclic pyridone Compound 4. The compound data is:
4 4
yield 67.2%; White needle-like crystals; 1H NMR (400 MHz, CDCl3): δ= 1.33(t, J= 7.12, 3H,CH3), 4.07(t, J= 9.64, 2H, NCH2), 4.27-4.33(m, 4H, CONCH2 andCOOCH2), 7.47(d, J= 8.08, 2H, ArH), 7.52(d, J= 8.16, 2H, ArH), 8.45 (s, 1H,CH), 8.71 (br, 1H, NH); HRMS (ESI-TOF+): m/z Calcd for C17H15O4N2ClNa[(M+Na)+]369.0613; found, 369.0617.yield 67.2%; White needle-like crystals; 1 H NMR (400 MHz, CDCl 3 ): δ = 1.33(t, J = 7.12 , 3H,CH 3 ), 4.07(t, J = 9.64 , 2H, NCH 2 ) , 4.27-4.33(m, 4H, CONCH 2 andCOOCH 2 ), 7.47(d, J = 8.08, 2H, ArH), 7.52(d, J = 8.16, 2H, ArH), 8.45 (s, 1H,CH), 8.71 (br, 1H, NH); HRMS (ESI-TOF + ): m/z Calcd for C 17 H 15 O 4 N 2 ClNa[(M+Na) + ]369.0613; found, 369.0617.
实施例5 称取2-(苯甲酰基亚甲基)六氢嘧啶(1mmol,202.3mg)于反应试管中,再缓慢向反应试管中滴入化合物1(5mmol,1081.1mg),在超声促进下25-30℃反应5小时,TLC点板监控反应,待反应充分后,反应混合物经过硅胶柱层析,减压旋蒸得白色固体,重结晶得纯净的白色针状晶体双环吡啶酮化合物5。化合物数据为:Example 5 Weigh 2-(benzoylmethylene)hexahydropyrimidine (1mmol, 202.3mg) into a reaction test tube, and then slowly drop compound 1 (5mmol, 1081.1mg) into the reaction test tube. React at 25-30°C for 5 hours, and monitor the reaction by spotting on TLC plate. After the reaction is complete, the reaction mixture is subjected to silica gel column chromatography and rotary evaporation under reduced pressure to obtain a white solid, which is recrystallized to obtain pure white needle-shaped bicyclic pyridone compound 5. The compound data is:
5 5
yield 95.4%; White needle-like crystals; 1H NMR (400 MHz, CDCl3): δ= 1.26(t, J= 7.04, 3H,CH3), 2.09(s, 2H, CH2), 3.51(s, 2H, NCH2), 4.05(d, J= 4.56,2H, CONCH2), 4.23(t, J= 7.00, 2H, COOCH2), 7.45(d, J= 3.24, 5H, ArH), 8.41 (s,1H, CH), 11.18 (br, 1H, NH); HRMS (ESI-TOF+): m/z Calcd for C18H18O4N2Na[(M+Na)+] 349.1159; found, 349.1155.yield 95.4%; White needle-like crystals; 1 H NMR (400 MHz, CDCl 3 ): δ = 1.26(t, J = 7.04 , 3H,CH 3 ), 2.09(s, 2H, CH 2 ), 3.51(s , 2H, NCH 2 ), 4.05(d, J = 4.56 , 2H, CONCH 2 ), 4.23(t, J = 7.00, 2H, COOCH 2 ), 7.45(d, J = 3.24, 5H, ArH), 8.41 ( s,1H, CH), 11.18 (br, 1H, NH); HRMS (ESI-TOF + ): m/z Calcd for C 18 H 18 O 4 N 2 Na[(M+Na) + ] 349.1159; found, 349.1155.
实施例6 称取化合物2-(对甲基苯甲酰基亚甲基)六氢嘧啶(1mmol,216.3mg)于反应试管中,再缓慢向反应试管中滴入化合物1(5mmol,1081.1mg),在超声促进下25-30℃反应5小时,TLC点板监控反应,待反应充分后,反应混合物经过硅胶柱层析,减压旋蒸得白色固体,重结晶得纯净的白色针状晶体双环吡啶酮化合物6。化合物数据为:Example 6 Weigh compound 2-(p-tolylmethylene)hexahydropyrimidine (1mmol, 216.3mg) into a reaction test tube, and then slowly drop compound 1 (5mmol, 1081.1mg) into the reaction test tube, Under the promotion of ultrasound, react at 25-30°C for 5 hours, and monitor the reaction by TLC spotting. After the reaction is complete, the reaction mixture is subjected to silica gel column chromatography and rotary evaporation under reduced pressure to obtain a white solid, which is recrystallized to obtain pure white needle-shaped bicyclic pyridine Ketone compound 6. The compound data is:
6 6
yield 84.3%; White needle-like crystals; 1H NMR (400 MHz, CDCl3): δ= 1.32(t, J= 7.08, 3H, CH3), 2.15(t, J= 5.32, 2H, CH2), 2.43(s, 3H, ArCH3), 3.56(s,2H, NCH2), 4.11(t, J= 5.76, 2H, CONCH2), 4.29(q, J=7.08, 2H, COOCH2), 7.28(d,J= 7.08, 2H, ArH), 7.43 (d, J= 7.64, 2H, COArH), 8.50 (s, 1H, CH), 11.24 (br,1H, NH); HRMS (ESI-TOF+): m/z Calcd for C19H20O4N2Na[(M+Na)+] 363.1315; found,363.1313.yield 84.3%; White needle-like crystals; 1 H NMR (400 MHz, CDCl 3 ): δ = 1.32(t, J = 7.08 , 3H, CH 3 ), 2.15(t, J = 5.32, 2H, CH 2 ) , 2.43(s, 3H, ArCH 3 ), 3.56(s,2H, NCH 2 ), 4.11(t, J = 5.76 , 2H, CONCH 2 ), 4.29(q, J =7.08, 2H, COOCH 2 ), 7.28 (d, J = 7.08, 2H, ArH), 7.43 (d, J = 7.64, 2H, COArH), 8.50 (s, 1H, CH), 11.24 (br,1H, NH); HRMS (ESI-TOF + ) : m/z Calcd for C 19 H 20 O 4 N 2 Na[(M+Na) + ] 363.1315; found,363.1313.
实施例7 称取化合物2-(对甲氧基苯甲酰基亚甲基)六氢嘧啶(1mmol,232.3mg)于反应试管中,再缓慢向反应试管中滴入化合物1(5mmol,1081.1mg),在超声促进下25-30℃反应5小时,TLC点板监控反应,待反应充分后,反应混合物经过硅胶柱层析,减压旋蒸得白色固体,重结晶得纯净的白色针状晶体双环吡啶酮化合物7。化合物数据为:Example 7 Weigh compound 2-(p-methoxybenzoylmethylene)hexahydropyrimidine (1mmol, 232.3mg) into a reaction test tube, and slowly drop compound 1 (5mmol, 1081.1mg) into the reaction test tube , reacted at 25-30°C for 5 hours under the promotion of ultrasound, and monitored the reaction by TLC spotting. After the reaction was complete, the reaction mixture was subjected to silica gel column chromatography, and the white solid was obtained by rotary evaporation under reduced pressure, which was recrystallized to obtain pure white needle-shaped bicyclic Pyridone compound 7. The compound data is:
7 7
yield 85.2%; White needle-like crystals; 1H NMR (400 MHz, CDCl3): δ= 1.34(t, J= 7.04, 3H, CH3), 2.16(t, J= 5.52, 2H, CH2), 3.90(s, 3H, ArOCH3), 3.57(s,2H, NCH2), 4.13(t, J= 5.72, 2H, CONCH2), 4.31(q, J=7.16, 2H, COOCH2), 6.99(d,J= 8.04, 2H, ArH), 7.54 (d, J= 7.96, 2H, COArH), 8.54 (s, 1H, CH), 11.21 (br,1H, NH); HRMS (ESI-TOF+): m/z Calcd for C19H20O5N2Na[(M+Na)+] 379.1264; found,379.1261.yield 85.2%; White needle-like crystals; 1 H NMR (400 MHz, CDCl 3 ): δ = 1.34(t, J = 7.04 , 3H, CH 3 ), 2.16(t, J = 5.52, 2H, CH 2 ) , 3.90(s, 3H, ArOCH 3 ), 3.57(s,2H, NCH 2 ), 4.13(t, J = 5.72 , 2H, CONCH 2 ), 4.31(q, J =7.16, 2H, COOCH 2 ), 6.99 (d, J = 8.04, 2H, ArH), 7.54 (d, J = 7.96, 2H, COArH), 8.54 (s, 1H, CH), 11.21 (br,1H, NH); HRMS (ESI-TOF + ) : m/z Calcd for C 19 H 20 O 5 N 2 Na[(M+Na) + ] 379.1264; found,379.1261.
实施例8 称取化合物2-(对氯苯甲酰基亚甲基)六氢嘧啶(1mmol,236.7mg)于反应试管中,再缓慢向反应试管中滴入化合物1(5mmol,1081.1mg),在超声促进下25-30℃反应5小时,TLC点板监控反应,待反应充分后,反应混合物经过硅胶柱层析,减压旋蒸得白色固体,重结晶得纯净的浅黄色片状晶体双环吡啶酮化合物8。化合物数据为:Example 8 Weigh compound 2-(p-chlorobenzoylmethylene)hexahydropyrimidine (1mmol, 236.7mg) into a reaction test tube, and slowly drop compound 1 (5mmol, 1081.1mg) into the reaction test tube. Under the promotion of ultrasound, react at 25-30°C for 5 hours, and monitor the reaction by TLC spotting. After the reaction is complete, the reaction mixture is subjected to silica gel column chromatography and rotary evaporation under reduced pressure to obtain a white solid, which is recrystallized to obtain pure light yellow flaky crystal bicyclopyridine Ketone compound 8. The compound data is:
8 8
yield 75.9%; Light yellow flaky crystal; 1H NMR (400 MHz, DMSO-d6): δ=1.15(t, J= 7.04, 3H, CH3), 2.01(s, 2H, CH2), 3.51(s, 2H, NCH2), 3.90(t, J=5.08, 2H, CONCH2), 4.09(q, J=7.00, 2H, COOCH2), 7.51(d, J= 8.24, 2H, ArH),7.60 (d, J= 8.20, 2H, COArH), 8.12 (s, 1H, CH), 10.80 (br, 1H, NH); HRMS(ESI-TOF+): m/z Calcd for C18H17O4N2ClNa[(M+Na)+] 383.0769; found, 383.0764.yield 75.9%; Light yellow flaky crystal; 1 H NMR (400 MHz, DMSO-d 6 ): δ =1.15(t, J = 7.04 , 3H, CH 3 ), 2.01(s, 2H, CH 2 ), 3.51( s, 2H, NCH 2 ), 3.90(t, J =5.08 , 2H, CONCH 2 ), 4.09(q, J =7.00, 2H, COOCH 2 ), 7.51(d, J = 8.24, 2H, ArH), 7.60 (d, J = 8.20, 2H, COArH), 8.12 (s, 1H, CH), 10.80 (br, 1H, NH); HRMS(ESI-TOF + ): m/z Calcd for C 18 H 17 O 4 N 2 ClNa[(M+Na) + ] 383.0769; found, 383.0764.
以上所述的具体实施例是对办发明的进一步说明,仅用于例证目的,并非对本发明任何形式的范围限制。凡对依据本发明的技术实质对以上实施例所做的简单修改、等同变化与修饰,均属本发明的保护范围。The specific embodiments described above are further descriptions of the invention, and are only for illustration purposes, and are not intended to limit the scope of the invention in any form. All simple modifications, equivalent changes and modifications made to the above embodiments according to the technical essence of the present invention belong to the protection scope of the present invention.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610734413.1A CN106366081A (en) | 2016-08-28 | 2016-08-28 | Green synthesis method for bicyclic pyridone compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610734413.1A CN106366081A (en) | 2016-08-28 | 2016-08-28 | Green synthesis method for bicyclic pyridone compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106366081A true CN106366081A (en) | 2017-02-01 |
Family
ID=57903375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610734413.1A Pending CN106366081A (en) | 2016-08-28 | 2016-08-28 | Green synthesis method for bicyclic pyridone compound |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106366081A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107674042A (en) * | 2017-09-28 | 2018-02-09 | 河南科技大学 | A kind of method of ultrasonic wave uninanned platform containing triazole and thiazole ring to Win4692 |
| CN111662282A (en) * | 2019-03-07 | 2020-09-15 | 湖南化工研究院有限公司 | Aza-and pyridine compounds and intermediates thereof |
| CN114507230A (en) * | 2020-11-17 | 2022-05-17 | 西华大学 | Bicyclic pyridone derivative, and synthesis method and application thereof |
-
2016
- 2016-08-28 CN CN201610734413.1A patent/CN106366081A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| KRISTJAN S. GUDMUNDSSON ET AL.: "《Synthesis and Antiviral Activity of Novel Erythrofuranosyl Imidazo[1,2-a]pyridine C-Nucleosides Constructed via Palladium Coupling of Iodoimidazo[1,2-a]pyridines and Dihydrofuran》", 《J. MED. CHEM.》 * |
| SHENGJIAO YAN ET AL.: "《Three-component solvent-free synthesis of highly substituted bicyclic pyridines containing a ring-junction nitrogen》", 《GREEN CHEM.》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107674042A (en) * | 2017-09-28 | 2018-02-09 | 河南科技大学 | A kind of method of ultrasonic wave uninanned platform containing triazole and thiazole ring to Win4692 |
| CN111662282A (en) * | 2019-03-07 | 2020-09-15 | 湖南化工研究院有限公司 | Aza-and pyridine compounds and intermediates thereof |
| CN111662282B (en) * | 2019-03-07 | 2021-07-06 | 湖南化工研究院有限公司 | Aza-and pyridine compounds and intermediates thereof |
| CN114507230A (en) * | 2020-11-17 | 2022-05-17 | 西华大学 | Bicyclic pyridone derivative, and synthesis method and application thereof |
| CN114507230B (en) * | 2020-11-17 | 2023-07-21 | 西华大学 | A kind of bicyclic pyridone derivatives, its synthesis method and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107163038B (en) | Chemical process | |
| CH620423A5 (en) | ||
| SE454273B (en) | CYCLIC HYDROXIIMIDES FOR USE IN THE PRODUCTION OF CYCLIC AMINO ACIDS AND PROCEDURES FOR THEIR PREPARATION | |
| SU659081A3 (en) | Method of obtaining phenylethylamines or salts thereof | |
| SU543341A3 (en) | Method for preparing benzylamine derivatives or their salts | |
| CN106366081A (en) | Green synthesis method for bicyclic pyridone compound | |
| CN116134023A (en) | Process for the preparation of aminofurans | |
| US8871916B2 (en) | Diaryl phosphine compounds | |
| DK156661B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF 1-AZAXANTON-3-CARBOXYLIC ACIDS | |
| US2502451A (en) | Amino-alkyl esters of diphenylamine 2-monocarboxylic acids | |
| CN104098507B (en) | A kind of hydroxyindole spirocyclopropane derivant and synthetic method thereof | |
| US2832780A (en) | Hydrazides of pyridazonyl-substituted alkanoic acids | |
| US4308206A (en) | Process for preparing derivatives of 5,11-dihydro-6h-pyrido[2,3-b][1,4]-benzodiazepin-6-one, and the final derivatives and synthesis intermediates obtained thereby | |
| US2569415A (en) | Imidazolines | |
| SU501675A3 (en) | The method of producing amino derivatives of pyrazolo (3,4-b) pyriline-5-ketones or their salts | |
| FI82245B (en) | FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA 5-AMINOALKYL--CARBOLINDERIVAT. | |
| IL26416A (en) | Basically substituted derivatives of 5,6-dihydro-dibenz-(b,e)-azepine-6,11-dione 11-oxime | |
| US2789111A (en) | Process for the manufacture of octahy- | |
| US3983126A (en) | Aryloxy pyridine carboxylic-4-acids | |
| EP0345464B1 (en) | Process for the preparation of substituted 3-amino-2-(benzoyl)acrylic acid esters as well as a process for the preparation of intermediates for antibacterial active agents from these compounds | |
| SU439964A1 (en) | Method for preparing naphthoquinone derivatives | |
| Almerico et al. | Polycondensed nitrogen heterocycles. Part 25. Aminopyrrolo [1, 2‐f]‐phenanthridines by decomposition of 2‐(3‐azidophenyl)‐1‐arylpyrroles | |
| CN106831786A (en) | A kind of synthetic method of pyrrolizines | |
| JP6169721B2 (en) | Method for synthesizing hydrazine that can be used in the treatment of papillomavirus | |
| SU422145A3 (en) | METHOD OF OBTAINING HETEROCYCLIC COMPOUNDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170201 |